title: Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial.
authors.forename: J
authors.initials: J
authors.lastname: Valk
authors.forename: F C
authors.initials: FC
authors.lastname: Crezée
authors.forename: R G
authors.initials: RG
authors.lastname: de Slegte
authors.forename: G J
authors.initials: GJ
authors.lastname: Hazenberg
authors.forename: J
authors.initials: J
authors.lastname: Wolbers
authors.forename: T
authors.initials: T
authors.lastname: Bach-Gansmo
mesh_terms: D000328:Adult; D000368:Aged; D002574:Cervical Vertebrae / Q000000981:diagnostic imaging; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007472:Iohexol / Q000009:adverse effects; D007479:Iopamidol / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009192:Myelography / Q000379:methods*; D011897:Random Allocation; D013129:Spinal Puncture
chemical_list: D007472:Iohexol; D007479:Iopamidol